XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Limited common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2022   62,163,739 9,164,193      
Beginning balance at Dec. 31, 2022 $ 447,894 $ 622 $ 92 $ 828,700 $ (379,138) $ (2,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Change in unrealized (loss) gain on marketable securities 1,483         1,483
Issuances of common stock upon stock option exercises (in shares)   186,201        
Issuances of common stock upon stock option exercises 867 $ 1   866    
Issuance of common stock upon vesting of RSUs and PRSUs (in shares)   12,075        
Stock-based compensation 10,880     10,880    
Net (loss) income 129,136       129,136  
Ending balance (in shares) at Mar. 31, 2023   62,362,015 9,164,193      
Ending balance at Mar. 31, 2023 590,260 $ 623 $ 92 840,446 (250,002) (899)
Beginning balance (in shares) at Dec. 31, 2022   62,163,739 9,164,193      
Beginning balance at Dec. 31, 2022 447,894 $ 622 $ 92 828,700 (379,138) (2,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Change in unrealized (loss) gain on marketable securities 1,891          
Net (loss) income 71,390          
Ending balance (in shares) at Sep. 30, 2023   62,823,295 9,164,193      
Ending balance at Sep. 30, 2023 563,581 $ 628 $ 92 871,100 (307,748) (491)
Beginning balance (in shares) at Mar. 31, 2023   62,362,015 9,164,193      
Beginning balance at Mar. 31, 2023 590,260 $ 623 $ 92 840,446 (250,002) (899)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Change in unrealized (loss) gain on marketable securities 216         216
Issuances of common stock upon stock option exercises (in shares)   340,229        
Issuances of common stock upon stock option exercises 4,698 $ 4   4,694    
Stock-based compensation 11,773     11,773    
Net (loss) income 4,278       4,278  
Ending balance (in shares) at Jun. 30, 2023   62,702,244 9,164,193      
Ending balance at Jun. 30, 2023 611,225 $ 627 $ 92 856,913 (245,724) (683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Change in unrealized (loss) gain on marketable securities 192         192
Issuances of common stock upon stock option exercises (in shares)   119,885        
Issuances of common stock upon stock option exercises 1,534 $ 1   1,533    
Issuance of common stock upon vesting of RSUs and PRSUs (in shares)   1,166        
Stock-based compensation 12,654     12,654    
Net (loss) income (62,024)       (62,024)  
Ending balance (in shares) at Sep. 30, 2023   62,823,295 9,164,193      
Ending balance at Sep. 30, 2023 563,581 $ 628 $ 92 871,100 (307,748) (491)
Beginning balance (in shares) at Dec. 31, 2023   62,977,316 9,164,193      
Beginning balance at Dec. 31, 2023 548,558 $ 630 $ 92 885,973 (338,418) 281
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Change in unrealized (loss) gain on marketable securities (353)         (353)
Issuances of common stock upon stock option exercises (in shares)   41,623        
Issuances of common stock upon stock option exercises 390     390    
Issuance of common stock upon vesting of RSUs and PRSUs (in shares)   170,964        
Issuance of common stock upon vesting of RSUs and PRSUs 2 $ 2        
Issuance of common stock upon ATM offering (in shares)   282,963        
Issuance of common stock in ATM offering 7,615 $ 3   7,612    
Stock-based compensation 12,218     12,218    
Net (loss) income (54,724)       (54,724)  
Ending balance (in shares) at Mar. 31, 2024   63,472,866 9,164,193      
Ending balance at Mar. 31, 2024 513,706 $ 635 $ 92 906,193 (393,142) (72)
Beginning balance (in shares) at Dec. 31, 2023   62,977,316 9,164,193      
Beginning balance at Dec. 31, 2023 548,558 $ 630 $ 92 885,973 (338,418) 281
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Change in unrealized (loss) gain on marketable securities 316          
Net (loss) income (146,907)          
Ending balance (in shares) at Sep. 30, 2024   63,681,858 9,164,193      
Ending balance at Sep. 30, 2024 449,425 $ 637 $ 92 933,424 (485,325) 597
Beginning balance (in shares) at Mar. 31, 2024   63,472,866 9,164,193      
Beginning balance at Mar. 31, 2024 513,706 $ 635 $ 92 906,193 (393,142) (72)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Change in unrealized (loss) gain on marketable securities (108)         (108)
Issuances of common stock upon stock option exercises (in shares)   57,533        
Issuances of common stock upon stock option exercises 558 $ 1   557    
Issuance of common stock upon vesting of RSUs and PRSUs (in shares)   50,644        
Issuance of common stock upon ATM offering (in shares)   40,122        
Issuance of common stock in ATM offering 1,063     1,063    
Stock-based compensation 12,808     12,808    
Net (loss) income (54,047)       (54,047)  
Ending balance (in shares) at Jun. 30, 2024   63,621,165 9,164,193      
Ending balance at Jun. 30, 2024 473,980 $ 636 $ 92 920,621 (447,189) (180)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Change in unrealized (loss) gain on marketable securities 777         777
Issuances of common stock upon stock option exercises (in shares)   52,783        
Issuances of common stock upon stock option exercises 406 $ 1   405    
Issuance of common stock upon vesting of RSUs and PRSUs (in shares)   7,910        
Stock-based compensation 12,398     12,398    
Net (loss) income (38,136)       (38,136)  
Ending balance (in shares) at Sep. 30, 2024   63,681,858 9,164,193      
Ending balance at Sep. 30, 2024 $ 449,425 $ 637 $ 92 $ 933,424 $ (485,325) $ 597